AVI-4126: Clinical Trials

1 trial of AVI-4126, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow AVI-4126: new trials by email Literature Review of AVI-4126 trials Research Report on AVI-4126

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacokinetic Study of a Single Dose of AVI-4126 (RESTEN-NG®) in Cerebral Spinal Fluid
AVI-4126 Injection (RESTEN-NG®) - Neoplasms
Phase 1CompletedSarepta Therapeutics, Inc.62006-06-012009-07-08

Conditions studied

Neoplasms (1)

Sponsors

Sarepta Therapeutics, Inc. (1)

Countries

United States (1)

Top investigators

Paula M Shaw, MD (1)